Ardelyx announces positive Stage 2b outcomes for tenapanor in IBS-C patients Ardelyx.

Ardelyx announces positive Stage 2b outcomes for tenapanor in IBS-C patients Ardelyx, Inc. , a clinical-stage biopharmaceutical firm focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b scientific trial evaluating tenapanor in individuals with constipation-predominant irritable bowel syndrome . Results out of this research demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to sufferers getting placebo nizagara100mg.net .

www.nizagara100mg.net

That’s why the authors considered it important to discover any possible nutritional interventions. ‘The modest, but significant statistically, influence of apple juice on the behavioral and emotional symptoms of dementia in this research increases the body of evidence supporting the usefulness of dietary approaches, including fruit and veggie juices, in delaying the onset and progression of Alzheimer’s Disease, even when confronted with known genetic risk elements,’ create the authors, Ruth Remington, RN, PhD, Amy Chan, PhD, Alicia Lepore, MS, Elizabeth Kotlya, MS, and Thomas B. Shea, PhD, ‘As in prior research with vitamin supplements, this implies that nutritional supplementation could be effective through the late stages of AD even.’..